Literature DB >> 23993379

Milk thistle: early seeds of potential.

Abby B Siegel1, Justin Stebbing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23993379      PMCID： PMC4116427          DOI： 10.1016/S1470-2045(13)70414-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  Efficacy of a galactogogue containing silymarin-phosphatidylserine and galega in mothers of preterm infants: a randomized controlled trial.

Authors:  E Zecca; A A Zuppa; A D'Antuono; E Tiberi; L Giordano; T Pianini; C Romagnoli
Journal:  Eur J Clin Nutr       Date:  2016-06-01       Impact factor: 4.016

2.  Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells.

Authors:  Yoshiki Nakashima; Chika Miyagi-Shiohira; Hirofumi Noguchi; Takeshi Omasa
Journal:  Mol Ther       Date:  2018-06-19       Impact factor: 11.454

3.  Mothers in Need of Lactation Support May Benefit from Early Postnatal Galactagogue Administration: Experience from a Single Center.

Authors:  Eleni Karapati; Alma Sulaj; Adamantia Krepi; Abraham Pouliakis; Nicoletta Iacovidou; Stella Paliatsiou; Rozeta Sokou; Paraskevi Volaki; Theodora Boutsikou; Zoi Iliodromiti
Journal:  Nutrients       Date:  2021-12-29       Impact factor: 5.717

4.  Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin.

Authors:  Joaquim Bosch-Barrera; Elia Sais; Noemí Cañete; Jordi Marruecos; Elisabet Cuyàs; Angel Izquierdo; Rut Porta; Manel Haro; Joan Brunet; Salvador Pedraza; Javier A Menendez
Journal:  Oncotarget       Date:  2016-05-31

5.  Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review.

Authors:  Anton Gillessen; Hartmut H-J Schmidt
Journal:  Adv Ther       Date:  2020-02-17       Impact factor: 3.845
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.